Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 10, 2018
Quasispecies characters of hepatitis B virus in immunoprophylaxis failure infantsXin Wang, Wanyan Deng, Keli Qian, et al.
Plos One|March 31, 2015
Lower mutation frequency of BCP/precore regions in e antigen-negative chronic HBV-infected children instead of adults patientsYong Huang, Haijun Deng, Xuefeng Shan, et al.
Frontiers in Cellular and Infection Microbiology|May 7, 2020
Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein LevelsBinli Mao, Zhuo Wang, Sidie Pi, et al.
Plos Pathogens|February 6, 2025
Host 3' flap endonuclease Mus81 plays a critical role in trimming the terminal redundancy of hepatitis B virus relaxed circular DNA during covalently closed circular DNA formationHu Zhang, Quanxin Long, Yuanjie Liu, et al.
Genes & Diseases|November 23, 2020
Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injuryYong Lin, Jun Yuan, Quanxin Long, et al.
Journal of Cellular Physiology|April 3, 2019
PE_PGRS62 promotes the survival of Mycobacterium smegmatis within macrophages via disrupting ER stress-mediated apoptosisQuanxin Long, Xiaohong Xiang, Qingqin Yin, et al.
Journal of Global Antimicrobial Resistance|December 27, 2016
Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014)Tian Meng, Xiaofeng Shi, Xuyang Gong, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 8, 2023
Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort studyWei Zheng, Xiaoxia Cao, Jing Luo, et al.
Future Microbiology|April 7, 2020
<i>Mycobacterium smegmatis msmeg_3314</i> is involved in pyrazinamide and fluoroquinolones susceptibility via NAD<sup>+</sup>/NADH dysregulationJunqi Xu, Yu Chen, Xi Mou, et al.
Emerging Microbes & Infections|March 21, 2020
L-lysine potentiates aminoglycosides against <i>Acinetobacter baumannii</i> via regulation of proton motive force and antibiotics uptakeWanyan Deng, Tiwei Fu, Zhen Zhang, et al.
Pageof 5